186 related articles for article (PubMed ID: 2296464)
1. Increased renal biosynthesis of prostaglandin E2 and thromboxane B2 in human congenital obstructive uropathy.
Kühl PG; Schönig G; Schweer H; Seyberth HW
Pediatr Res; 1990 Jan; 27(1):103-7. PubMed ID: 2296464
[TBL] [Abstract][Full Text] [Related]
2. Reference intervals and developmental changes in urinary prostanoid excretion in healthy newborns, infants and children.
Leonhardt A; Busch C; Schweer H; Seyberth HW
Acta Paediatr; 1992 Mar; 81(3):191-6. PubMed ID: 1511190
[TBL] [Abstract][Full Text] [Related]
3. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
[TBL] [Abstract][Full Text] [Related]
4. [Obstructive nephropathy; kidney function and renal excretion of prostaglandin (E)2 and Thromboxane B(2) following percutaneous decompression nephropyelostomy].
Weber T; Sauer A; Brühl P; Kramer HJ
Urologe A; 1988 Sep; 27(5):269-74. PubMed ID: 3176214
[TBL] [Abstract][Full Text] [Related]
5. Thromboxane B2 and prostaglandin E2 in the rat kidney with unilateral ureteral obstruction.
Whinnery MA; Shaw JO; Beck N
Am J Physiol; 1982 Mar; 242(3):F220-5. PubMed ID: 6950670
[TBL] [Abstract][Full Text] [Related]
6. In vivo prostanoid formation during acute renal allograft rejection.
Tönshoff B; Busch C; Schweer H; Schärer K; Seyberth HW
Nephrol Dial Transplant; 1993; 8(7):631-6. PubMed ID: 8396748
[TBL] [Abstract][Full Text] [Related]
7. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
[TBL] [Abstract][Full Text] [Related]
8. Role of glomerular eicosanoid production in the obstructed kidney.
Fukuzaki A; Morrissey J; Klahr S
Int Urol Nephrol; 1993; 25(6):525-31. PubMed ID: 8175271
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor.
Chiabrando C; Broggini M; Castelli MG; Cozzi E; Castagnoli MN; Donelli MG; Garattini S; Giavazzi R; Fanelli R
Cancer Res; 1987 Feb; 47(4):988-91. PubMed ID: 3100032
[TBL] [Abstract][Full Text] [Related]
10. Eicosanoid excretion from the contralateral kidney in pigs with complete unilateral ureteral obstruction.
Frøkiaer J; Sørensen SS
J Urol; 1995 Sep; 154(3):1205-9. PubMed ID: 7637089
[TBL] [Abstract][Full Text] [Related]
11. Excretion of primary prostanoids and their metabolites during acute volume expansion.
Seyberth HW; Tulassay T; Kühl PG; Soeding K; Rascher W; Schweer H
Prostaglandins; 1988 Feb; 35(2):221-32. PubMed ID: 3163156
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
[TBL] [Abstract][Full Text] [Related]
13. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904.
Yoshida T; Ichikawa Y; Tojo T; Homma M
Lupus; 1996 Apr; 5(2):129-38. PubMed ID: 8743126
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of renal thromboxane biosynthesis increased sodium excretion rate in normal and saline-loaded rats.
Papanicolaou N; Gkika EL; Gkikas G; Bariety J
Clin Sci (Lond); 1985 Jan; 68(1):79-82. PubMed ID: 3880524
[TBL] [Abstract][Full Text] [Related]
15. Increased thromboxane metabolites excretion in liver cirrhosis.
Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
[TBL] [Abstract][Full Text] [Related]
16. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
Livio M; Benigni A; Zoja C; Begnis R; Morelli C; Rossini M; Garattini S; Remuzzi G
J Pharmacol Exp Ther; 1989 Jan; 248(1):334-41. PubMed ID: 2492341
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of 6-keto-prostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome).
Rimola A; Ginés P; Arroyo V; Camps J; Pérez-Ayuso RM; Quintero E; Gaya J; Rivera F; Rodés J
J Hepatol; 1986; 3(1):111-7. PubMed ID: 3462243
[TBL] [Abstract][Full Text] [Related]
18. Unusual metabolism of prostacyclin in infants with persistent septic pulmonary hypertension.
Schweer H; Seyberth HW; Kühl PG; Meese CO
Eicosanoids; 1990; 3(4):237-42. PubMed ID: 2073401
[TBL] [Abstract][Full Text] [Related]
19. [Prostaglandin E2, F2 alpha,6-keto-prostaglandin F1 alpha and thromboxane B2 in the placenta of normotensive women and women with pregnancy induced hypertension].
Gao J
Zhonghua Fu Chan Ke Za Zhi; 1989 Nov; 24(6):331-3, 380. PubMed ID: 2632162
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor is a potent stimulus for renal prostaglandin synthesis: possible significance in unilateral ureteral obstruction.
Weisman SM; Felsen D; Vaughan ED
J Pharmacol Exp Ther; 1985 Oct; 235(1):10-5. PubMed ID: 3862805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
